{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:25:27Z","timestamp":1773059127741,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Brincidofovir (<jats:styled-content style=\"fixed-case\">BCV<\/jats:styled-content>) is a broad\u2010spectrum antiviral agent active <jats:italic>in vitro<\/jats:italic> against double\u2010stranded <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> viruses including herpesviruses, adenoviruses, polyomaviruses, and poxviruses. We report successful <jats:styled-content style=\"fixed-case\">BCV<\/jats:styled-content> use in management of disseminated acyclovir\u2010 and cidofovir\u2010resistant varicella zoster virus in an immunocompromised hematopoietic stem cell transplant patient with chronic graft\u2010versus\u2010host disease who was intolerant to foscarnet.<\/jats:p>","DOI":"10.1111\/tid.12583","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T14:09:41Z","timestamp":1470233381000},"page":"785-790","source":"Crossref","is-referenced-by-count":16,"title":["Brincidofovir treatment of acyclovir\u2010resistant disseminated varicella zoster virus infection in an immunocompromised host"],"prefix":"10.1111","volume":"18","author":[{"given":"K.M.","family":"Mullane","sequence":"first","affiliation":[{"name":"Medicine University of Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nuss","sequence":"additional","affiliation":[{"name":"Medicine University of Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ridgeway","sequence":"additional","affiliation":[{"name":"Medicine University of Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.N.","family":"Prichard","sequence":"additional","affiliation":[{"name":"Pediatrics University of Alabama at Birmingham Birmingham Alabama USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.","family":"Hartline","sequence":"additional","affiliation":[{"name":"Pediatrics University of Alabama at Birmingham Birmingham Alabama USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Theusch","sequence":"additional","affiliation":[{"name":"Medicine University of Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mommeja\u2010Marin","sequence":"additional","affiliation":[{"name":"Chimerix, Inc. Durham North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Larson","sequence":"additional","affiliation":[{"name":"Medicine University of Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.06.002"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.6.1172"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.4.1424.1424"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70004-8"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70051-6"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"e_1_2_6_8_1","first-page":"495","article-title":"Long\u2010term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia","volume":"10","author":"Sempere A","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3624"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-077644"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.99"},{"key":"e_1_2_6_12_1","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications","volume":"13","author":"Han CS","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2012.01824.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1218-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12180"},{"issue":"8","key":"e_1_2_6_16_1","first-page":"867","article-title":"Varicella\u2010zoster virus disease is more frequent after cord blood than after bone marrow transplantation","volume":"14","author":"Vandenbosch K","year":"2008","journal-title":"Biol"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704959"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(02)00021-3"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.7.1.1"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1787"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis879"},{"key":"e_1_2_6_22_1","first-page":"1","volume-title":"Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard","author":"Swierkosz EM","year":"2004"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/324503"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.04.005"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.3.678"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303688"},{"key":"e_1_2_6_27_1","volume-title":"Brincidofovir for Prevention of Cytomegalovirus after Allogeneic Hematopoietic Cell Transplantation in CMV\u2010Seropositive Patients: A Randomized, Double\u2010Blind, Placebo\u2010Controlled, Parallel\u2010Group Phase 3 Trial","author":"Marty FM"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12583","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T02:27:16Z","timestamp":1696040836000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1111\/tid.12583"],"URL":"https:\/\/doi.org\/10.1111\/tid.12583","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}